Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume -, Issue -, Pages 1-9
Publisher
Informa UK Limited
Online
2020-12-11
DOI
10.1080/10428194.2020.1856833
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma
- (2020) Naoki Ozeki et al. International Journal of Clinical Oncology
- Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma
- (2020) Se-Il Go et al. BMC CANCER
- Prognostic impact of low muscle mass and low muscle density in patients with diffuse large B-cell lymphoma
- (2020) Hánah N. Rier et al. LEUKEMIA & LYMPHOMA
- Metabolic and Molecular Basis of Sarcopenia: Implications in the Management of Urothelial Carcinoma
- (2019) Hiroshi Fukushima et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Evaluation of the impact of psoas muscle index, a parameter of sarcopenia, in patients with esophageal squamous cell carcinoma receiving neoadjuvant therapy
- (2019) Yohei Ozawa et al. Esophagus
- OUP accepted manuscript
- (2018) AGE AND AGEING
- A comparison of pectoralis versus lumbar skeletal muscle indices for defining sarcopenia in diffuse large B-cell lymphoma - two are better than one
- (2017) Se-Il Go et al. Oncotarget
- A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy
- (2017) Ryo Kasahara et al. Biomed Research International
- Implication of Psoas Muscle Index on Survival for Hepatocellular Carcinoma Undergoing Radiofrequency Ablation Therapy
- (2017) Yukihisa Yuri et al. Journal of Cancer
- Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy
- (2016) Daphne Y. Xiao et al. AMERICAN JOURNAL OF HEMATOLOGY
- Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults
- (2016) Yuhei Hamaguchi et al. NUTRITION
- Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
- (2016) Se-Il Go et al. Journal of Cachexia Sarcopenia and Muscle
- Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy
- (2016) Michael P. Chu et al. Journal of Cachexia Sarcopenia and Muscle
- Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma
- (2015) Nobuhiko Nakamura et al. ANNALS OF HEMATOLOGY
- Estimation of sarcopenia prevalence using various assessment tools
- (2015) C. Beaudart et al. EXPERIMENTAL GERONTOLOGY
- Sarcopenia is associated with autologous transplant-related outcomes in patients with lymphoma
- (2015) Megan V. Caram et al. LEUKEMIA & LYMPHOMA
- The Histological Classification of Diffuse Large B-cell Lymphomas
- (2015) Yi Xie et al. SEMINARS IN HEMATOLOGY
- Skeletal Muscle Radio-Density Is an Independent Predictor of Response and Outcomes in Follicular Lymphoma Treated with Chemoimmunotherapy
- (2015) Michael P. Chu et al. PLoS One
- An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
- (2013) Z. Zhou et al. BLOOD
- Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
- (2013) Hélène Lanic et al. LEUKEMIA & LYMPHOMA
- Validity and Reliability of Tools to Measure Muscle Mass, Strength, and Physical Performance in Community-Dwelling Older People: A Systematic Review
- (2012) Donja M. Mijnarends et al. Journal of the American Medical Directors Association
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation